SGYP Insider Trading Activity and SEC Form 4 Filings
SGYP insider trading summary
No open-market insider purchases or sales of Synergy Pharmaceuticals, Inc. (SGYP) have been reported on SEC Form 4 in the past 12 months.
Latest SGYP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 10, 2017 | Paulson & Co. Inc. | 10% Owner | Sell | $24.7M (8,750,000 @ $2.82) |
| Aug 7, 2017 | Paulson & Co. Inc. | 10% Owner | Sell | $99K (26,200 @ $3.77) |
| Aug 7, 2017 | Paulson & Co. Inc. | 10% Owner | Sell | $329 (87 @ $3.78) |
| May 26, 2017 | John P Brancaccio | Director | Buy | $23K (6,500 @ $3.59) |
| May 26, 2017 | Gary S Jacob | Chief Executive Officer | Buy | $20K (5,680 @ $3.52) |
| Nov 4, 2016 | Paulson & Co. Inc. | 10% Owner | Sell | $594K (140,000 @ $4.24) |
| Sep 28, 2016 | Paulson & Co. Inc. | 10% Owner | Sell | $116K (20,700 @ $5.60) |
| Sep 27, 2016 | Paulson & Co. Inc. | 10% Owner | Sell | $193K (33,600 @ $5.75) |
| Sep 19, 2016 | John P Brancaccio | Director | Sell | $15K (2,518 @ $5.76) |
| Sep 19, 2016 | Paulson & Co. Inc. | 10% Owner | Sell | $8.4M (1,500,000 @ $5.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.